Wendy Harpham on Healthy Survivorship

Revoking FDA Approval: Right or Wrong? - Part VI

In light of recent events in my personal life forcing uncharacteristic delays between posts, I'll review briefly what I've discussed so far before continuing the discussion about the FDA's recent revocation of approval Avastin for treatment of breast cancer.

Revoking FDA Approval: Right or Wrong? - Part V

Now let's look at the players who influenced the FDA's decision to revoke approval of Avastin for breast cancer. The complex process requires a book-length manuscript to fully explain. Rather than abandon my effort, here are the bare bones:

Revoking FDA Approval: Right or Wrong? - Part IV

My last post provided an outline of the FDA's approval process. I cringed while writing it, knowing 250 words couldn't capture the investment of time, people and capital. 

Revoking FDA Approval: Right or Wrong - Part III

In my November 28th and December 3rd posts I introduced the media storm regarding the FDA's recent revocation of approval of Avastin for the treatment of breast cancer. Today I'll provide an overview of the FDA approval process to help us talk about the controversy.

Managing Uncertainty: Hope

In my October 20 and November 19th posts I provided links to the first two essays of a 4-part series on managing uncertainty. In the November 25th issue of Oncology Times, you can read part 3, titled Managing Uncertainty: Hope.

Here's the problem: Patients' reactions to uncertainty may interfere with Healthy Survivorship.

Holding Note

When I was in practice, after seeing a patient in the hospital I would occasionally write a so-called holding note in the patient's chart. This was a synopsis that indicated I'd return later to complete the evaluation and write a proper admission note.

It was common practice to write a holding note if other patients' urgent needs pulled me away.

Revoking FDA Approval: Right or Wrong? Part II

To judge the FDA's recent revocation of approval for Avastin for breast cancer, let's go back to basics. What is the job of the FDA?